Ore Holdings Overview
- Year Founded
-
1995
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
5
- Investments
-
2
Ore Holdings General Information
Description
Operator of a drug asset development company. The company is focused on acquiring and developing clinical-stage drug development companies aimed at enhancing the value of the entities within its portfolio.
Contact Information
Website
www.oreholdings.comCorporate Office
- 590 Madison Avenue
- New York, NY 10022
- United States
Corporate Office
- 590 Madison Avenue
- New York, NY 10022
- United States
Ore Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ore Holdings Patents
Ore Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20110319461-A1 | Novel salts, polymorphs, and synthetic processes regarding imidazole derivative | Inactive | 13-Jan-2010 | ||
| US-20100204286-A1 | Method for reducing gastrointestinal adverse effects of cytotoxic agents | Inactive | 12-Feb-2009 | ||
| US-20100105746-A1 | Method for treating metabolic diseases | Inactive | 01-Aug-2008 | ||
| US-20100137403-A1 | Method for enhancing cognition or inhibiting cognitive decline | Inactive | 10-Jul-2008 | ||
| EP-2323662-A1 | Treating inflammation and related conditions with irindalone | Inactive | 10-Jul-2008 | A61K31/496 |
Ore Holdings Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ore Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ore Holdings Investments & Acquisitions (2)
Ore Holdings’s most recent deal was a Merger/Acquisition with TherImmune Research for . The deal was made on 01-Apr-2003.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TherImmune Research | 01-Apr-2003 | Merger/Acquisition | Biotechnology | ||
| Metabometrix | 29-Jun-2001 | Early Stage VC | Diagnostic Equipment |
Ore Holdings Exits (1)
Ore Holdings’s most recent exit was on 29-Jun-2001 from Metabometrix. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Metabometrix | 29-Jun-2001 | Completed |
|
Ore Holdings FAQs
-
When was Ore Holdings founded?
Ore Holdings was founded in 1995.
-
Where is Ore Holdings headquartered?
Ore Holdings is headquartered in New York, NY.
-
What is the size of Ore Holdings?
Ore Holdings has 7 total employees.
-
What industry is Ore Holdings in?
Ore Holdings’s primary industry is Private Equity.
-
Is Ore Holdings a private or public company?
Ore Holdings is a Private company.
-
What is Ore Holdings’s current revenue?
The current revenue for Ore Holdings is .
-
How much funding has Ore Holdings raised over time?
Ore Holdings has raised $29M.
-
Who are Ore Holdings’s investors?
Steel Partners Holdings has invested in Ore Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
